1-3 of 3
Anders Österborg, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

T Cells from Chronic Lymphocytic Leukemia (CLL) Patients Display Dysregulated Expression of Immune Checkpoint Molecules and Activation Markers Mainly Restricted to CD4 + Cells and Correlated with Disease Activity

Marzia Palma, MDPhD, Giusy Gentilcore, MSc, Fariba Mozaffari, PhD, Kia Heimersson, Barbro Näsman-Glaser, Lotta Hansson, MD PhD, Anders Österborg, MDPhD, Håkan Mellstedt, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4132.
https://doi.org/10.1182/blood.V126.23.4132.4132
Published: 2015
Journal Articles

A Phase 2 Study of Alemtuzumab-Ofatumumab (A+O) Combination in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) - an Update

Jeanette Lundin, MD PhD, Steven T. Rosen, MD, Anders Österborg, MDPhD, Olga Frankfurt, MD, Jane N. Winter, MD, Alfred Rademaker, Jennifer Kreutzer, Elizabeth Bacon, Sonja Sönnert-Husa, Shuo Ma, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1734.
https://doi.org/10.1182/blood.V126.23.1734.1734
Published: 2015
Journal Articles

Real-World Results on Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Data from 97 Swedish Patients Treated in a Compassionate Use Program

Lotta Hansson, MD PhD, Maria Winqvist, MD, Anna Asklid, MD, P-O Andersson, MDPhD, Karin Karlsson, MD, Claes Karlsson, MDPhD, Birgitta Lauri, MD, Jeanette Lundin, MD PhD, Mattias Mattsson, MD, Stefan Norin, MDPhD, Anna Sandstedt, MD, Anders Österborg, MDPhD
Journal: Blood
Blood (2015) 126 (23): 1745.
https://doi.org/10.1182/blood.V126.23.1745.1745
Published: 2015